Blanket Purchase Agreement HT001425A0012
Award Date
6/13/25
Last Date to Order
6/12/30
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc. The single-award IDV contract, valued at $6.5 million, has a period of performance through July 2028. It is established against the Pharmaceuticals and Drugs GSA Schedule and covers a comprehensive range of diagnostic nuclear imaging supplies and agents, including radiopharmaceuticals, contrast media, and other nuclear medicine...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Pharmarx Hawaii LLC, a minority-owned, Asian-Pacific American, for-profit limited liability company, to provide radiopharmaceutical supplies to Tripler Army Medical Center in Hawaii. The single-award BPA has a total ceiling value of $1,250,000 and a period of performance through April 30, 2026. The contract does not utilize any set-asides. As a BPA, this vehicle allows the DHA to place task orders for...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
This Blanket Purchase Agreement (BPA) is a $1,500,000.00 single-award federal contract IDV awarded by the Defense Health Agency (DHA) to the prime contractor, Sofie CO. The BPA, valid through February 27, 2029, is for the procurement of pharmaceutical supplies. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is a specialized supplier of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the Department of Veterans Affairs (VA) and DHA. The...
This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract has a total ceiling value of $6,900,000 and a period of performance through September 30, 2025. The primary purpose of this contract is to procure the radiopharmaceutical product PLUVICTO, which is used in cancer treatment and diagnostic...
The Defense Health Agency (DHA) has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Lantheus Medical Imaging, Inc., a wholly-owned subsidiary of Lantheus Holdings, Inc. These contracts, valued at over $1 million in total ceiling, facilitate the procurement of radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents for military treatment facilities and other federal healthcare providers. Lantheus, a for-profit manufacturer specializing in innovative...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement (BPA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, to provide radiopharmaceutical products and services to support diagnostic imaging and treatment procedures at Naval Hospital Pensacola in Florida. The BPA has a potential value of $150,000 and a period of performance from October 11, 2023, to October 10, 2028. Jubilant Radiopharma is...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sr-Services GMBH on April 1, 2023. The BPA has a potential value of $725,000 and expires on April 23, 2028. It was not subject to any set-aside requirements. The BPA aims to procure radiopharmaceuticals for use in nuclear medical services. Sr-Services GMBH will supply these products to support the Defense Health Agency's mission of providing health care services to U.S. military service members, military families,...